Ventus Therapeutics
- Founded: 2019
- Location: Waltham, MA
- Employee range: 11 - 50
- Clinical stage: Clin0
- Therapy area: Immunology, Rheumatology
- Drug types: IMM, RHU, DRM, NEU, GI, HEP, NPH, CVV
- Lead product: VENT-03
- Product link: https://www.ventustx.com/pipeline/pipeline/
- Funding: $140M C Feb 2022; $100M Apr 2021; $60M A May 2020
- Investors: Versant Ventures
ventustx.com linkedin.com job board
Short description:
Small Molecules targeting proteins in the inflammasome and nucleic acid sensing signaling pathways
Drug notes:
VENT-02 Clin1 neuro; VENT-01 Clin0 renal, cardiovascular, hepatic; VENT-05 RD undisclosed; VENT-04 RD various
Long description:
Contact us to add description.
Jobs:
© 2023 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com